2908, 2023 Prometheus Laboratories Surpasses 35 Million Covered Lives Under Positive Medical Policy for Anser® Therapeutic Drug MonitoringKen Chueh2023-08-29T06:13:02-07:002023-08-29| News & Events Prometheus [...]Read More
108, 2023 Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser® TestingKen Chueh2023-08-29T06:07:13-07:002023-08-01| News & Events Prometheus [...]Read More
2707, 2023 Prometheus Laboratories Announces the Launch of PredictrPK® ADA, A Precision-Guided Dosing Test for Optimization of AdalimumabKen Chueh2023-07-26T15:59:06-07:002023-07-27| News & Events Prometheus [...]Read More
205, 2023 Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease ResearchKen Chueh2023-07-18T16:09:33-07:002023-05-02| News & Events Lynx.MD [...]Read More
203, 2023 Prometheus Launches New Indication for PredictrPK® IFX, A Precision-Guided Dosing Test for IBDNicole Drago2023-04-12T22:31:38-07:002023-03-02| News & Events [...]Read More
1409, 2022 Prometheus Laboratories Announces Partnership with Takeda to Launch CDPATH™, a Personalized Prognostic Tool Advancing Innovation for Crohn’s Disease PatientsJudy Gohndrone2022-09-14T16:21:35-07:002022-09-14| News & Events [...]Read More